Regulations.gov document
Acknowledgment Letter from FDA DDM to Ajanta Pharma USA Inc
Other · FDA-2019-P-2559 · posted May 28, 2019
Key facts
| Document ID | FDA-2019-P-2559-0002 |
|---|---|
| Title | Acknowledgment Letter from FDA DDM to Ajanta Pharma USA Inc |
| Document type | Other |
| Subtype | Acknowledgement Letter/Receipt |
| Agency | FDA |
| Docket | FDA-2019-P-2559 |
| Posted | May 28, 2019 |
| Comment period opens | May 28, 2019 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: